O8Z3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sonoma Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.72 EUR Market Closed

Market Cap: €51.7m

S	Sonoma Pharmaceuticals Inc F:O8Z3	US
W	Williams-Sonoma Inc F:WM1	US
C	Charter Hall Group OTC:CTOUF	AU

Profitability Summary

Sonoma Pharmaceuticals Inc's profitability score is 18/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

37%

Gross Margin is Increasing

35% > 38%

Negative Operating Margin

-13%

Negative 3Y Average Operating Margin

-29%

Operating Margin is Increasing

-37% > -13%

Negative Net Margin

-16%

Negative 3Y Average Net Margin

-31%

Net Margin is Increasing

-45% > -16%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-40% > -21%

Negative ROE

-85%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-41%

ROIC is Increasing

-45% > -27%

View All

Hide

Collapse

18 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.